Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human IL-13 R alpha 2 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 23 publications
Supplier: R&D Systems AF146SP
This item is not returnable.
View return policy
Description
IL-13R alpha 2 Polyclonal specifically detects IL-13R alpha 2 in Human samples. It is validated for Western Blot, Simple Western, Flow Cytometry, Immunohistochemistry, Blockade of Receptor-ligand Interaction, CyTOF-ready.Specifications
IL-13R alpha 2 | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
cancer/testis antigen 19, CD213a2, CD213a2 antigen, CT19, IL-13 receptor subunit alpha-2, IL13BP, IL13R, IL-13R, IL13R alpha 2, IL-13R subunit alpha-2, IL13RA2, IL-13RA2, IL-13R-alpha-2, interleukin 13 binding protein, interleukin 13 receptor alpha 2 chain, interleukin 13 receptor, alpha 2, interleukin-13 receptor subunit alpha-2, Interleukin-13-binding protein | |
Goat | |
Affinity Purified | |
RUO | |
3598 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Flow Cytometry, Immunohistochemistry, Blockade of Receptor-ligand Interaction | |
LYOPH | |
Western Blot 0.2 ug/mL, Simple Western 10 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, Blockade of Receptor-ligand Interaction, CyTOF-ready | |
Q14627 | |
IL13RA2 | |
Mouse myeloma cell line NS0-derived recombinant human IL-13 R alpha 2 Cys22-Leu342 Accession # Q14627 | |
25 μg | |
Primary | |
Detects human IL-13 R alpha 2 in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross-reactivity with recombinant mouse IL-13 R alpha 2 is observed and less than 1% cross-reactivity with recombinant human IL-13 R alpha 1 is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction